Holen Sie sich die Stockscreener-App
7.39
1.86%
-0.14
Vorhandelsmarkt:
7.22
-0.17
-2.30%
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
Alpha Tau to Present Alpha DaRT–Pembrolizumab Head and Neck Cancer Data at AHNS 2026 - TipRanks
Alpha Tau abstract on cancer therapy accepted for presentation By Investing.com - Investing.com Canada
Elderly head and neck cancer study gets AHNS podium slot - Stock Titan
Alpha Tau (DRTS) wins AHNS podium slot for Alpha DaRT and pembrolizumab head and neck cancer study - Stock Titan
Alpha Tau pancreatic data: 19 of 19 controlled, 8 device events - Stock Titan
Alpha Tau reports disease control in pancreatic cancer trial By Investing.com - Investing.com Australia
Alpha Tau reports disease control in pancreatic cancer trial - Investing.com
Alpha Tau Reports 100% Local Disease Control in Alpha DaRT Pancreatic Cancer Trials Presented at DDW 2026 - TipRanks
Alpha Tau Announces 100% Local Disease Control Rate and - GlobeNewswire
[EFFECT] Alpha Tau Medical Ltd. SEC Filing - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Reaches New 1-Year HighTime to Buy? - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Trading Up 13.6%Here's What Happened - MarketBeat
Alpha Tau Medical (NASDAQ: DRTS) files $300M shelf; $100M ATM pact - Stock Titan
Alpha Tau to Present Pooled Pancreatic Cancer Alpha DaRT Data at 2026 ASCO Meeting - TipRanks
Alpha Tau abstract accepted at ASCO annual meeting in May - Investing.com
Alpha Tau abstract accepted at ASCO annual meeting in May By Investing.com - Investing.com Canada
Alpha Tau Announces Presentation of Pancreatic Cancer Data - GlobeNewswire
Alpha Tau (Nasdaq: DRTS) ASCO abstract pools 58 pancreatic cancer patients - Stock Titan
H.C. Wainwright reiterates Alpha Tau Medical stock rating on FDA approval - Investing.com
H.C. Wainwright reiterates Alpha Tau Medical stock rating on FDA approval By Investing.com - Investing.com South Africa
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Alpha Tau Wins FDA Clearance To Expand Alpha DaRT Pancreatic Cancer Trial - RTTNews
Alpha Tau Treats First European Pancreatic Cancer Patient With Alpha DaRT in ACAPELLA Trial - TipRanks
Alpha Tau (NASDAQ: DRTS) advances Alpha DaRT pancreatic cancer clinical trials - Stock Titan
Alpha Tau expands pancreatic cancer trial to 40, adds second chemo - Stock Titan
Alpha Tau Successfully Treats First Pancreatic Cancer - GlobeNewswire
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Alpha Tau Medical (DRTS) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr
Alpha Tau Medical (DRTS) Investor presentation Summary - Quartr
Alpha Tau Medical (DRTS) 2nd Annual Lytham Partners Healthcare Investor Summit summary - Quartr
Is Alpha Tau (DRTS) stock trading at a discount | Q4 2025: Profit Exceeds ViewsPopular Market Picks - Cổng thông tin điện tử Tỉnh Sơn La
DRTS (Alpha Tau Medical Ltd. Ordinary Shares) posts narrower Q4 2025 loss than estimates, shares rise 0.75 percent today.GDR - Cổng thông tin điện tử tỉnh Lào Cai
S Morry Blumenfeld Net Worth (2026) - GuruFocus
Alan Adler Net Worth (2026) - GuruFocus
Maya Netser Net Worth (2026) - GuruFocus
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY) - The Globe and Mail
Michael Avruch Net Worth (2026) - GuruFocus
Uzi Sofer Net Worth (2026) - GuruFocus
Raphi Levy Net Worth (2026) - GuruFocus
Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 20.56% Potential Upside in Biotechnology - DirectorsTalk Interviews
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Update - MarketBeat
DRTS Options Volatility — NASDAQ:DRTS - TradingView
DRTS Options Chain — NASDAQ:DRTS - TradingView
Shorts Report: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M A2026 Earnings Surprises & High Return Trade Guides - baoquankhu1.vn
Growth Recap: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandQuarterly Trade Review & High Conviction Investment Ideas - baoquankhu1.vn
Jobs Data: Can Alpha Tau Medical Ltd continue delivering strong returnsEarnings Overview Summary & Safe Capital Preservation Plans - baoquankhu1.vn
ETFs Investing in Alpha Tau Medical Ltd Stocks - TradingView
Apella Capital LLC Buys New Position in Alpha Tau Medical Ltd. $DRTS - MarketBeat
FOMO Trade: Will Alpha Tau Medical Ltd Equity Warrant stock benefit from M A2026 Geopolitical Influence & AI Based Trade Execution Alerts - baoquankhu1.vn
Daytona Street Capital LLC Invests $749,000 in Alpha Tau Medical Ltd. $DRTS - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Shares Up 5.2%Here's What Happened - MarketBeat
DRTS PE Ratio & Valuation, Is DRTS Overvalued - Intellectia AI
DRTS SEC FilingsAlpha Tau Medical Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Alpha Emitter Market Set to Boom Rapidly, Witnessing Strong - openPR.com
DRTSW Stock Analysis: Alpha Tau Medical Ltd. Warrant falls 8.16% to $0.9 amid short-term bearish pressure - UBND thành phố Hải Phòng
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com
Stop Loss: How does Alpha Tau Medical Ltd compare to its peersTrade Signal Summary & Weekly Breakout Stock Alerts - baoquankhu1.vn
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW - TipRanks
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Aug Update: What is Alpha Tau Medical Ltd Equity Warrants market position2026 EndofYear Setup & Growth Focused Investment Plans - baoquankhu1.vn
Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data - TipRanks
Aug EndMonth: Why is Alpha Tau Medical Ltd stock going down2026 Sentiment & Daily Profit Maximizing Tips - baoquankhu1.vn
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):